专题：Inflammasome and immune disorders

This cluster of papers focuses on the molecular mechanisms of inflammasome activation, regulation, and its role in inflammatory responses, cell death (pyroptosis), and immune-related diseases. It covers topics such as NLRP3 inflammasome, interleukin-1, caspase-1, and the involvement of mitochondria in inflammasome activation.
最新文献
SARS-CoV-2-induced damage to rat cortical neuronal networks ex vivo is mediated by the pro-inflammatory activation of the cGAS-STING pathway

article Full Text OpenAlex

Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome

article Full Text OpenAlex

Current Evidence and Future Directions for Colchicine in the Prevention of Atherosclerotic Cardiovascular Disease

article Full Text OpenAlex

An animal model of NLRC4-associated autoinflammation and infantile enterocolitis reveals novel therapeutic strategies

article Full Text OpenAlex

NLRP1 under pressure: An overview of the NLRP1 inflammasome as a sensor of cellular stress

review Full Text OpenAlex

Targeting the NLRP3 inflammasome with natural products for ischemia–reperfusion injury across organs: mechanisms, structure–activity relationships, and delivery innovations

review Full Text OpenAlex

DAMPs in the immunogenicity of cell death

review Full Text OpenAlex

Engineering macrophage phenotype switching via nucleotide‐binding oligomerization domain‐like receptor protein 3 inflammasome inhibition: A translational approach using antibiotic cement for diabetic foot ulcers

article Full Text OpenAlex

Shuxuetong injection promotes skin flap survival by inhibiting pyroptosis mediated by the TLR4/NF-κB/NLRP3 signaling pathway

article Full Text OpenAlex

The NLRP3 inflammasome: a pivotal orchestrator of multisystem diseases—from molecular mechanisms to therapeutic innovation

review Full Text OpenAlex

近5年高被引文献
Multiple early factors anticipate post-acute COVID-19 sequelae

article Full Text OpenAlex 1120 FWCI191.18984754

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

review Full Text OpenAlex 944 FWCI115.19273187

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

article Full Text OpenAlex 929 FWCI158.2495008

Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation

review Full Text OpenAlex 891 FWCI165.24666279

Mitochondrial control of inflammation

review Full Text OpenAlex 836 FWCI101.90126281

Death by TNF: a road to inflammation

review Full Text OpenAlex 755 FWCI92.30186849

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research

review Full Text OpenAlex 742 FWCI150.80529031

Regulated cell death (RCD) in cancer: key pathways and targeted therapies

review Full Text OpenAlex 693 FWCI153.2799585

Cell death

article Full Text OpenAlex 674 FWCI332.81132701

NLRP3 and pyroptosis blockers for treating inflammatory diseases

review Full Text OpenAlex 662 FWCI80.48722932